Is Transcatheter Aortic Valve Replacement Better Than Surgical Aortic Valve Replacement in Patients With Chronic Obstructive Pulmonary Disease? A Nationwide Inpatient Sample Analysis

Background Chronic obstructive pulmonary disease ( COPD ) patients are at increased risk of respiratory related complications after cardiac surgery. It is unclear whether transcatheter aortic valve replacement ( TAVR ) or surgical aortic valve replacement ( SAVR ) results in favorable outcomes among COPD patients. Methods and Results Patients were identified from the Nationwide Inpatient Sample database from 2011 to 2014. Patients with age ≥60, COPD , and either went transarterial TAVR or SAVR were included in the analysis. A 1:1 propensity‐matched cohort was created to examine the outcomes. A matched pair of 1210 TAVR and 1208 SAVR patients was identified. Respiratory‐related complications such as tracheostomy (0.8% versus 5.8%; odds ratio [ OR ], 0.14; P OR , 0.63; P =0.002), reintubation (6.5% versus 10.0%; OR , 0.49; P OR , 0.41; P TAVR versus SAVR . Use of noninvasive mechanical ventilation was similar between TAVR and SAVR (4.1% versus 4.8%; OR , 0.84; P =0.41). Non‐respiratory‐related complications, such as in‐hospital mortality (3.3% versus 4.2%; OR , 0.64; P =0.035), bleeding requiring transfusion (9.9% versus 21.7%; OR , 0.38; P OR , 0.63; P OR , 0.19; P TAVR than SAVR . Cost ($56 099 versus $63 146; P P TAVR than SAVR . Conclusions TAVR portended significantly fewer respiratory‐related complications compared with SAVR in COPD patients. TAVR may be a preferable mode of aortic valve replacement in COPD patients.